AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $169.6M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.55pm 07/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 6.7¢ | Day High | 7.5¢ | Day Low | 6.7¢ | |||
| Daily Volume | 20529097 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 7.1¢ | 215833 | 0 | 7.2¢ | 168409 | |
Directors & Senior Management
| Mr. Angus Peterson | Chief Financial Officer |
| Mr. Daniel Rigby Jauncey | Non-Executive Director |
| Mr. David Francis Quinlivan | Non-Executive Director |
| Mr. David Newling | Non-Executive Chairman |
| Jane Morgan | Investor & Media Relations Manager |
| Mr. Jaroslaw Krzysztof Kopias | Company Secretary |
| Mr. Michael Kevin Hansel | Independent Non-Executive Director |
| Mr. Neil Eugene Meadows | Non-Executive Director |
| Mr. Sean Westbrook | Non-Executive Director |
| Mr. Shane O’Connell | Chief Operating Officer |
Data source: ADVFN
